These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33007022)

  • 1. The mode of action of the Protein tyrosine phosphatase 1B inhibitor Ertiprotafib.
    Kumar GS; Page R; Peti W
    PLoS One; 2020; 15(10):e0240044. PubMed ID: 33007022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel PTP1B inhibitors via pharmacophore-oriented scaffold hopping from Ertiprotafib.
    Liu JZ; Zhang SE; Nie F; Yang Y; Tang YB; Yin W; Tian JY; Ye F; Xiao Z
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6217-22. PubMed ID: 24148325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta).
    Shrestha S; Bhattarai BR; Cho H; Choi JK; Cho H
    Bioorg Med Chem Lett; 2007 May; 17(10):2728-30. PubMed ID: 17407812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms.
    Erbe DV; Wang S; Zhang YL; Harding K; Kung L; Tam M; Stolz L; Xing Y; Furey S; Qadri A; Klaman LD; Tobin JF
    Mol Pharmacol; 2005 Jan; 67(1):69-77. PubMed ID: 15475571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview.
    Khator R; Biharee A; Bhatia N; Kulkarni S; Singh Y; Karthikeyan C; Jain AK; Thareja S
    Curr Med Chem; 2024; 31(34):5535-5549. PubMed ID: 37711015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
    Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
    Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
    Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
    Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over t-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening.
    Reddy MV; Ghadiyaram C; Panigrahi SK; Hosahalli S; Mangamoori LN
    Mini Rev Med Chem; 2013 Oct; 13(11):1602-6. PubMed ID: 24000798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Dynamics Simulations of A27S and K120A Mutated PTP1B Reveals Selective Binding of the Bidentate Inhibitor.
    Chen X; Liu X; Gan Q; Feng C; Zhang Q
    Biomed Res Int; 2019; 2019():9852897. PubMed ID: 30729132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual Screening of Novel and Selective Inhibitors of Protein Tyrosine Phosphatase 1B over T-Cell Protein Tyrosine Phosphatase Using a Bidentate Inhibition Strategy.
    Chen X; Gan Q; Feng C; Liu X; Zhang Q
    J Chem Inf Model; 2018 Apr; 58(4):837-847. PubMed ID: 29608303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of Fullerene Derivatives as Novel Potent Inhibitors of Protein Tyrosine Phosphatase 1B: Insight into the Inhibitory Mechanism through Molecular Modeling Studies.
    Qian M; Shan Y; Guan S; Zhang H; Wang S; Han W
    J Chem Inf Model; 2016 Oct; 56(10):2024-2034. PubMed ID: 27649447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation.
    Wu J; Ma Y; Zhou H; Zhou L; Du S; Sun Y; Li W; Dong W; Wang R
    Biochem Biophys Res Commun; 2020 May; 526(1):273-280. PubMed ID: 32209254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design strategy of selective PTP1B inhibitors over TCPTP.
    Li X; Wang L; Shi D
    Bioorg Med Chem; 2016 Aug; 24(16):3343-52. PubMed ID: 27353889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors.
    Devi B; Vasishta SS; Das B; Baidya ATK; Rampa RS; Mahapatra MK; Kumar R
    Mol Divers; 2024 Apr; 28(2):649-669. PubMed ID: 36745307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.
    Maheshwari N; Karthikeyan C; Trivedi P; Moorthy NSHN
    Curr Drug Targets; 2018; 19(5):551-575. PubMed ID: 28228082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B.
    Jin T; Yu H; Huang XF
    Sci Rep; 2016 Feb; 6():20766. PubMed ID: 26865097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
    Malamas MS; Sredy J; Moxham C; Katz A; Xu W; McDevitt R; Adebayo FO; Sawicki DR; Seestaller L; Sullivan D; Taylor JR
    J Med Chem; 2000 Apr; 43(7):1293-310. PubMed ID: 10753467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Phenylpropanoic acid-based phosphotyrosine (pTyr) mimetics: hit evolution to a novel orally active protein tyrosine phosphatase 1B (PTP1B) inhibitor.
    Tang YB; Liu JZ; Zhang SE; Du X; Nie F; Tian JY; Ye F; Huang K; Hu JP; Li Y; Xiao Z
    ChemMedChem; 2014 May; 9(5):918-21. PubMed ID: 24644278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel competitive inhibitor of PTP1B by high-throughput screening.
    Shi L; Yu HP; Zhou YY; Du JQ; Shen Q; Li JY; Li J
    Acta Pharmacol Sin; 2008 Feb; 29(2):278-84. PubMed ID: 18215359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.